AI Tool can detect over 1000 diseases
MILTON a computer algorithm has been developed to investigate patient test results commonly collected by GPs to detect patterns in
Latvia’s Strategic Plan to Improve Access to Medicines Aligned with WHO Recommendations
Latvia has unveiled a new roadmap aimed at improving access to medicines, in accordance with the World Health Organization (WHO)
NHS Approves First-Ever Drug for Von Hippel-Lindau Disease, Offering New Hope for Patients
NHS patients in England with von Hippel-Lindau (VHL) disease now have access to the first-ever drug specifically approved for their
Czechs Embrace Preventive Healthcare as Post-Pandemic Trend Grows
A surge in preventive healthcare in Czechia marks a positive shift in public health behavior, as citizens increasingly focus on
NHS Launches Historic RSV Vaccine Campaign for Vulnerable Groups
In a groundbreaking public health initiative, the NHS has officially launched its first-ever vaccination program against respiratory syncytial virus (RSV)
WHO Calls for Rapid Access to Mpox Diagnostic Tests, Invites Manufacturers for Emergency Use Review
The World Health Organization (WHO) has called on manufacturers of mpox in vitro diagnostics (IVDs) to submit expressions of interest
Enhanced Brain Scans May Improve Long-Term Outcomes for Concussion Patients, Study Suggests
Concussion patients often face persistent and severe symptoms following a head injury, yet traditional diagnostic methods frequently fall short in
Scientists to Harness AI in Analyzing Brain Scans to Develop Dementia Risk Prediction Tool
A team of scientists and researchers is embarking on a groundbreaking project to analyze hundreds of thousands of brain scans
Alzheimer’s Drug Shows Potential for Life-Saving Suspended Animation in Emergency Medicine
Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University have successfully induced a hibernation-like state in tadpoles
Mpox Epidemic Declared a Public Health Emergency by WHO
The World Health Organization (WHO) has declared the surge of mpox in the Democratic Republic of the Congo (DRC) and
